NasdaqCM - Delayed Quote • USD
Mereo BioPharma Group plc (MREO)
At close: May 14 at 4:00 PM EDT
After hours: May 14 at 7:57 PM EDT
Major Holders
Breakdown | |
---|---|
0.54% | % of Shares Held by All Insider |
62.28% | % of Shares Held by Institutions |
62.62% | % of Float Held by Institutions |
81 | Number of Institutions Holding Shares |
Top Institutional Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
Rubric Capital Management LP | 13.55M | Mar 31, 2024 | 20.01% | 40,116,871 |
Soleus Capital Management, L.P. | 9.78M | Dec 31, 2023 | 14.43% | 28,941,160 |
Mangrove Partners | 8.75M | Dec 31, 2023 | 12.92% | 25,908,563 |
Rock Springs Capital Management, LP | 7.98M | Dec 31, 2023 | 11.79% | 23,632,199 |
Suvretta Capital Management, LLC | 7.37M | Dec 31, 2023 | 10.88% | 21,817,680 |
683 Capital Management LLC | 6.2M | Dec 31, 2023 | 9.15% | 18,352,000 |
Alkeon Capital Management LLC | 4.24M | Dec 31, 2023 | 6.26% | 12,544,776 |
Tejara Capital Ltd | 3.71M | Dec 31, 2023 | 5.48% | 10,990,861 |
Clearline Capital, LP | 3.33M | Dec 31, 2023 | 4.91% | 9,847,085 |
Adage Capital Partners GP L.L.C. | 2.65M | Dec 31, 2023 | 3.91% | 7,844,000 |
Top Mutual Fund Holders
Holder | Shares | Date Reported | % Out | Value |
---|---|---|---|---|
abrdn Healthcare Investors | 1.06M | Dec 31, 2023 | 1.57% | 3,148,845 |
abrdn Life Sciences Investors | 487.28k | Dec 31, 2023 | 0.72% | 1,442,357 |
Tema ETF Tr-Tema Cardiovascular and Metabolic ETF | 371.47k | Feb 29, 2024 | 0.55% | 1,099,557 |
ETF Opportunities Tr-Formidable ETF | 319.39k | Dec 31, 2023 | 0.47% | 945,394 |
Tema ETF Tr-Tema Oncology ETF | 150.31k | Feb 29, 2024 | 0.22% | 444,908 |
Fidelity NASDAQ Composite Index Fund | 96.63k | Mar 31, 2024 | 0.14% | 286,024 |
Trust For Professional Managers-PMC Diversified Equity Fund | 55.9k | Mar 31, 2024 | 0.08% | 165,472 |
Trust for Professional Managers-ActivePassive International Equity ETF | 26.6k | Feb 29, 2024 | 0.04% | 78,736 |
John Hancock Fds II-Health Sciences Fund | 28.2k | Feb 29, 2024 | 0.04% | 83,472 |
Primecap Odyssey Aggressive Growth Fund | 10k | Mar 31, 2024 | 0.01% | 29,600 |
Related Tickers
PDSB PDS Biotechnology Corporation
3.5350
-1.53%
XFOR X4 Pharmaceuticals, Inc.
0.9854
+0.90%
MDNAF Medicenna Therapeutics Corp.
1.9000
+3.83%
DAWN Day One Biopharmaceuticals, Inc.
16.62
+3.55%
EFTR eFFECTOR Therapeutics, Inc.
2.0000
0.00%
CRVS Corvus Pharmaceuticals, Inc.
2.2600
+7.11%
CLRB Cellectar Biosciences, Inc.
3.1800
+3.92%
LPTX Leap Therapeutics, Inc.
2.7500
-2.83%
INZY Inozyme Pharma, Inc.
4.6300
+2.66%
CYTK Cytokinetics, Incorporated
59.36
+2.54%